Trial Profile
Phase I Study of WST11 Phototherapy for Upper Tract Urothelial Carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2023
Price :
$35
*
At a glance
- Drugs Padeliporfin (Primary)
- Indications Carcinoma; Pelvic cancer; Renal cancer; Ureteral neoplasms; Urogenital cancer
- Focus Adverse reactions
- 13 Dec 2023 Planned End Date changed from 1 Aug 2024 to 2 Dec 2024.
- 13 Dec 2023 Planned primary completion date changed from 1 Aug 2024 to 2 Dec 2024.
- 13 Dec 2023 Status changed from completed to active, no longer recruiting.